EZ-Tet-pLKO-Puro Citations (5)

Plasmid Article: A streamlined method for the design and cloning of shRNAs into an optimized Dox-inducible lentiviral vector.
Frank SB, Schulz VV, Miranti CK BMC Biotechnol. 2017 Feb 28;17(1):24. doi: 10.1186/s12896-017-0341-x. PubMed Journal

---

Articles Citing EZ-Tet-pLKO-Puro

Articles
Patient-specific cancer genes contribute to recurrently perturbed pathways and establish therapeutic vulnerabilities in esophageal adenocarcinoma. Mourikis TP, Benedetti L, Foxall E, Temelkovski D, Nulsen J, Perner J, Cereda M, Lagergren J, Howell M, Yau C, Fitzgerald RC, Scaffidi P, Ciccarelli FD. Nat Commun. 2019 Jul 15;10(1):3101. doi: 10.1038/s41467-019-10898-3. PubMed
Protein neddylation as a therapeutic target in pulmonary and extrapulmonary small cell carcinomas. Norton JP, Augert A, Eastwood E, Basom R, Rudin CM, MacPherson D. Genes Dev. 2021 Jun;35(11-12):870-887. doi: 10.1101/gad.348316.121. Epub 2021 May 20. PubMed
Visualization of endogenous p27 and Ki67 reveals the importance of a c-Myc-driven metabolic switch in promoting survival of quiescent cancer cells. La T, Chen S, Guo T, Zhao XH, Teng L, Li D, Carnell M, Zhang YY, Feng YC, Cole N, Brown AC, Zhang D, Dong Q, Wang JY, Cao H, Liu T, Thorne RF, Shao FM, Zhang XD, Jin L. Theranostics. 2021 Sep 21;11(19):9605-9622. doi: 10.7150/thno.63763. eCollection 2021. PubMed
DUSP4 Inactivation Leads to Reduced Extracellular SignalRegulated Kinase Activity through Upregulation of DUSP6 in Melanoma Cells. Kamada H, Yasuhira S, Shibazaki M, Amano H, Maesawa C. J Invest Dermatol. 2022 Sep;142(9):2499-2507.e6. doi: 10.1016/j.jid.2022.02.007. Epub 2022 Feb 19. PubMed
A commercial ARHGEF17/TEM4 antibody cross-reacts with Nuclear Mitotic Apparatus protein 1 (NuMA). Prifti DK, Lauzier A, Elowe S. PLoS One. 2022 Jul 1;17(7):e0268848. doi: 10.1371/journal.pone.0268848. eCollection 2022. PubMed

If you have published an article using this plasmid, please email us at to have your article added to this page.